Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
BMJ Case Rep ; 17(6)2024 Jun 19.
Article de Anglais | MEDLINE | ID: mdl-38901856

RÉSUMÉ

The risks and benefits of spinal anaesthesia must be assessed in patients with coagulation disorders. A woman in her 20s with congenital factor VII (FVII) deficiency (31%) was admitted at 38 weeks for caesarean delivery. A rotational thromboelastometry (ROTEM) analysis showed normal coagulation and spinal anaesthesia was performed safely. A repeated ROTEM analysis after haemostasis and uterine closure showed normal coagulation without fibrinolysis. No prophylactic FVII was administered, resulting in a cost savings of US$12 884. FVII level did not predict bleeding or fibrinolysis and FVII and tranexamic acid were not indicated.


Sujet(s)
Anesthésie obstétricale , Rachianesthésie , Césarienne , Déficit en facteur VII , Thromboélastographie , Humains , Femelle , Rachianesthésie/méthodes , Thromboélastographie/méthodes , Grossesse , Déficit en facteur VII/complications , Déficit en facteur VII/sang , Anesthésie obstétricale/méthodes , Adulte , Complications hématologiques de la grossesse/sang
2.
Reg Anesth Pain Med ; 27(3): 284-8, 2002.
Article de Anglais | MEDLINE | ID: mdl-12016602

RÉSUMÉ

BACKGROUND AND OBJECTIVES: Because of its short duration, hyperbaric lidocaine has been a popular intrathecal drug to provide anesthesia for postpartum tubal ligation (PPTL). However, reports of transient symptoms associated with its use have prompted the search for alternative intrathecal local anesthetics for short procedures. Hyperbaric bupivacaine is rarely associated with transient neurologic symptoms, and we designed this study to determine the optimal dose of bupivacaine for PPTL that assures adequate sensory block and allows the patient the shortest recovery time. METHODS: Forty American Society of Anesthesiologists (ASA) I-II patients undergoing spinal anesthesia for PPTL were randomly assigned to receive 5.0, 7.5, 10.0, or 12.5 mg hyperbaric bupivacaine in the right lateral position. RESULTS: Despite sensory block above T-8 in all groups, 4 of the 5 patients in the 5-mg group developed blocks insufficiently dense for surgery and required general anesthesia. Failed spinals occurred evenly in the remaining groups. Motor regression was significantly more rapid with decreasing doses of bupivacaine. Time in the postanesthesia care unit (PACU) was shorter in the 7.5-mg group. CONCLUSIONS: Hyperbaric bupivacaine 7.5 mg injected in the lateral position provides adequate surgical anesthesia for PPTL with a minimal duration of motor block and recovery time.


Sujet(s)
Rachianesthésie , Anesthésiques locaux , Bupivacaïne , Stérilisation tubaire , Adulte , Anesthésiques locaux/administration et posologie , Anesthésiques locaux/effets indésirables , Bupivacaïne/administration et posologie , Bupivacaïne/effets indésirables , Études croisées , Relation dose-effet des médicaments , Méthode en double aveugle , Femelle , Hémodynamique/effets des médicaments et des substances chimiques , Humains , Injections rachidiennes , Mesure de la douleur/effets des médicaments et des substances chimiques , Période du postpartum , Modèles des risques proportionnels
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...